"0003-0213-01" National Drug Code (NDC)

NDC Code	0003-0213-01
Package Description	28 TABLET in 1 BOTTLE (0003-0213-01)
Product NDC	0003-0213
Product Type Name	HUMAN PRESCRIPTION DRUG
Proprietary Name	Daklinza
Non-Proprietary Name	Daclatasvir
Dosage Form	TABLET
Usage	ORAL
Start Marketing Date	20150727
End Marketing Date	20200630
Marketing Category Name	NDA
Application Number	NDA206843
Manufacturer	E.R. Squibb & Sons, L.L.C.
Substance Name	DACLATASVIR DIHYDROCHLORIDE
Strength	30
Strength Unit	mg/1
Pharmacy Classes	Hepatitis C Virus NS5A Inhibitor [EPC],P-Glycoprotein Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA]